Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 436
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Edmonton, Spokane WA, Abbotsford British Columbia,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Edmonton, Tacoma WA, Denver CO, Scottsdale AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase 3, Recruiting
Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2)
for
Knee Osteoarthritis, Hip Osteoarthritis
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT07055113
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
for
Opioid-use Disorder
Location: Edmonton, Calgary, Vancouver
Sponsor: University of British Columbia
Sex: All
Age: 18+
Code: NCT04893525
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
for
Acute Respiratory Distress Syndrome, Infections
Location: Edmonton, Calgary, North Vancouver, Rochester MN,
Sponsor: BioAegis Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05947955
Phase 2, Recruiting
A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress
for
Mild Respiratory Distress
Location: Edmonton, Montreal
Sponsor: NuvOx LLC
Sex: All
Age: 18+
Code: NCT06658535
Phase 1, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Edmonton, Kamloops, Abbotsford British Columbia,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Sherwood Park, Calgary, Regina, Missoula MT,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sherwood Park, Calgary, Kelowna, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)
for
Wrist Arthritis, Wrist Arthropathy,
Location: St. Albert, Calgary, Saskatoon, London, Ottawa
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT04580225
Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
for
Heart Failure
Location: Edmonton, Calgary, Surrey, North Vancouver, Victoria,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06033950
Phase 3, Recruiting
Improving the Stewardship of Diagnostic Imaging Resources in Alberta Emergency Departments
for
Brain Injuries, Pulmonary Embolism
Location: Edmonton, Edmontyon, Sherwood Park, St. Albert,
Sponsor: University of Calgary
Sex: All
Age: 16+
Code: NCT02410941
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients